Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3851

Introduced
6/6/23  
Refer
6/6/23  

Caption

Access to Breast Cancer Diagnosis Act of 2023

Impact

The bill amends the Public Health Service Act, thereby impacting the regulations around health insurance coverage related to breast examinations. By mandating coverage without cost-sharing, it is expected to increase the utilization of necessary diagnostic procedures. The act acknowledges that while it prohibits cost-sharing, it allows for certain prerequisites like prior authorization, which helps insurance providers manage approvals. Additionally, it ensures that state laws offering greater protections remain in effect, emphasizing the balance between federal and state health coverage regulations.

Summary

House Bill 3851, known as the Access to Breast Cancer Diagnosis Act of 2023, seeks to enhance access to necessary breast cancer diagnostic and supplemental examinations by removing cost-sharing obligations for patients. Specifically, it prohibits group health plans and health insurance issuers from imposing any deductibles, copayments, or coinsurance for these services. This legislation aims to alleviate financial barriers that can prevent individuals from seeking timely diagnosis and treatment for breast cancer, potentially leading to improved health outcomes and early detection among women and high-risk individuals.

Contention

Notable points of contention surrounding HB3851 may arise from differing opinions on the balance of cost-sharing models in health insurance. Supporters argue that removing these financial barriers is crucial in combating breast cancer effectively, particularly for populations that may be financially vulnerable. On the other hand, critics of such mandates might express concerns about the broader implications for insurance premiums and the financial sustainability of health plans, as higher coverage levels may lead to increased overall costs to insurers and, subsequently, policyholders.

Companion Bills

US SB2464

Related Access to Breast Cancer Diagnosis Act of 2023

Previously Filed As

US SB2464

Access to Breast Cancer Diagnosis Act of 2023

US HB3037

Access to Breast Cancer Diagnosis Act of 2025

US SB1500

Access to Breast Cancer Diagnosis Act of 2025

US S584

Breast Cancer Diagnostic Imaging Reform

US SB2219

Health insurance plans; prohibit from imposing cost sharing requirement for breast cancer screening, diagnostic breast exams.

US HB60

An Act To Amend Titles 18, 29, And 31 Relating To Breast Cancer Screening And Diagnostic Procedures.

US HF71

A bill for an act relating to insurance coverage for diagnostic breast cancer examinations.(See HF 2489.)

US SB2858

Health benefit plans; set provisions related to diagnostic breast exams and individualized investigational drugs.

US HB1296

Relative to insurance coverage for diagnostic and supplemental breast examinations.

US H0575

Coverage for Diagnostic and Supplemental Breast Examinations

Similar Bills

CA SB257

Health care coverage: diagnostic imaging.

CA SB974

Health care coverage: diagnostic imaging.

IL HB5115

IDPH-DIAGNOSTIC ALGORITHM

IL HB1002

IDPH-DIAGNOSTIC ALGORITHM

CA AB2024

Health care coverage: diagnostic imaging.

TX HB1809

Relating to the registration of diagnostic imaging equipment, the accreditation of diagnostic imaging facilities, and the regulation of diagnostic imaging providers; providing penalties.

CA SB639

Medical professionals: course requirements.

TX SB1461

Relating to the registration of diagnostic imaging equipment, the accreditation of diagnostic imaging facilities, and the regulation of diagnostic imaging providers; providing penalties.